Search results for "guideline"

showing 10 items of 800 documents

An international assessment of the adoption of enhanced recovery after surgery (ERAS®) principles across colorectal units in 2019–2020

2021

Aim The Enhanced Recovery After Surgery (ERAS® ) Society guidelines aim to standardise perioperative care in colorectal surgery via 25 principles. We aimed to assess the variation in uptake of these principles across an international network of colorectal units. Method An online survey was circulated amongst European Society of Coloproctology members in 2019/20. For each ERAS® principle, respondents were asked to score how frequently the principle was implemented in their hospital, from 1 ('rarely') to 4 ('always'). Respondents were also asked to recall whether practice had changed since 2017. Subgroup analyses based on hospital characteristics were conducted. Results Of hospitals approache…

medicine.medical_specialtyPrehabilitationmedicine.medical_treatmentMEDLINEColorectal NeoplasmPerioperative CareNOmedicineHumans03.02. Klinikai orvostanPerioperative OptimisationEnhanced recovery after surgeryDigestive System Surgical ProceduresLS7_4Enhanced Recovery After Surgery (ERAS)business.industryGastroenterologyDigestive System Surgical ProcedureGuidelineColorectal surgeryEnhanced Recovery After Surgery (ERAS); Perioperative Optimisation; SurgeryFamily medicinePerioperative careNasogastric intubationSurgeryPreoperative fastingColorectal NeoplasmsEnhanced Recovery After SurgerybusinessColorectal SurgeryHumanColorectal Disease
researchProduct

Modern Strategies in the Prevention of Implant-Associated Infections

2005

The application of medical devices either for temporary or permanent use has become an indispensible part of almost all fields of medicine. However, foreign bodies are associated with a substantial risk of bacterial and fungal infections. Implant-associated infections significantly contribute to the still increasing problem of nosocomial infections. To reduce the incidence of such infections, specific guidelines providing evidence-based recommendations and comprising both technological and nontechnological strategies for prevention have been established. Strict adherence to hygienic rules during insertion or implantation of the device are aspects of particular importance. Besides such basi…

medicine.medical_specialtyProsthesis-Related InfectionsFuture studiesmedicine.drug_class0206 medical engineeringAntibioticsBiomedical EngineeringMedicine (miscellaneous)New materialsBioengineering02 engineering and technologyBiologyProsthesis DesignBacterial AdhesionBiomaterialsCoated Materials BiocompatiblemedicineHumansConnective Tissue ProteinsIntensive care medicineForeign BodiesInfection ControlGeneral Medicine021001 nanoscience & nanotechnologyAntimicrobial020601 biomedical engineeringAnti-Bacterial AgentsSurgeryPractice Guidelines as TopicEquipment Contamination0210 nano-technologyThe International Journal of Artificial Organs
researchProduct

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017

2017

AbstractTherapeutic drug monitoring (TDM) is the quantification and interpretation of drug concentrations in blood to optimize pharmacotherapy. It considers the interindividual variability of pharmacokinetics and thus enables personalized pharmacotherapy. In psychiatry and neurology, patient populations that may particularly benefit from TDM are children and adolescents, pregnant women, elderly patients, individuals with intellectual disabilities, patients with substance abuse disorders, forensic psychiatric patients or patients with known or suspected pharmacokinetic abnormalities. Non-response at therapeutic doses, uncertain drug adherence, suboptimal tolerability, or pharmacokinetic drug…

medicine.medical_specialtyPsychopharmacologyGuidelines as Topic030226 pharmacology & pharmacy03 medical and health sciencesNeuropharmacology0302 clinical medicinePharmacotherapyHealth caremedicineHumansPharmacology (medical)PsychiatryIntensive care medicinePsychotropic Drugsmedicine.diagnostic_testbusiness.industryMental DisordersGeneral Medicinemedicine.disease3. Good healthAntiparkinson drugNeuropsychopharmacologySubstance abusePsychiatry and Mental healthTolerabilityTherapeutic drug monitoringDrug Monitoringbusiness030217 neurology & neurosurgeryPharmacogeneticsPharmacopsychiatry
researchProduct

Pharmacogenetics in Neuroblastoma: What Can Already Be Clinically Implemented and What Is Coming Next?

2021

Pharmacogenetics is one of the cornerstones of Personalized Precision Medicine that needs to be implemented in the routine of our patients’ clinical management in order to tailor their therapies as much as possible, with the aim of maximizing efficacy and minimizing toxicity. This is of great importance, especially in pediatric cancer and even more in complex malignancies such as neuroblastoma, where the rates of therapeutic success are still below those of many other types of tumors. The studies are mainly focused on germline genetic variants and in the present review, state of the art is presented: which are the variants that have a level of evidence high enough to be implemented in the c…

medicine.medical_specialtyQH301-705.5Antineoplastic AgentsReviewchemotherapyPediatricsCatalysisInorganic ChemistryNeuroblastomadrug labelQuimioteràpiamedicineHumansMedical physicsBiology (General)Precision MedicinePhysical and Theoretical Chemistryclinical implementation guidelinesQD1-999SNP (single nucleotide polymorphism)Molecular BiologySpectroscopybusiness.industryOrganic ChemistryGenetic variantsGeneral MedicineEvidence-based medicinePrecision medicinePediatric cancerComputer Science ApplicationsChemistryPharmacogeneticsFarmacogenèticabusinessPharmacogenetics
researchProduct

Quality assurance in the treatment of colorectal cancer: the EURECCA initiative

2014

Colorectal cancer is one of the most common cancers in Europe. Over the past few decades, important advances have been made in screening, staging and treatment of colorectal cancer. However, considerable variation between and within European countries remains, which implies that further improvements are possible. The most important remaining question now is: when are we, health care professionals, delivering the best available care to patients with colon or rectal cancer? Currently, quality assurance is a major issue in colorectal cancer care and quality assurance awareness is developing in almost all disciplines involved in the treatment of colorectal cancer patients. Quality assurance has…

medicine.medical_specialtyQuality managementQuality Assurance Health CareColorectal cancercolorectal cancerauditAuditquality assurancemultidisciplinarityFeedbackHealth caremedicineHumansguidelinesIntensive care medicineQuality of Health CareSettore MED/36 - DIAGNOSTICA PER IMMAGINI E RADIOTERAPIAClinical Trials as TopicClinical Auditbusiness.industryCancerHematologyGuidelinemedicine.diseaseSurgeryEuropeClinical trialOncologyData Interpretation StatisticalPractice Guidelines as TopicColorectal NeoplasmsbusinessQuality assurance
researchProduct

Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement

2020

Genome sequencing and gene-based therapies appear poised to advance the management of rare lipoprotein disorders and associated dyslipidaemias. However, in practice, underdiagnosis and undertreatment of these disorders are common, in large part due to interindividual variability in the genetic causes and phenotypic presentation of these conditions. To address these challenges, the European Atherosclerosis Society formed a task force to provide practical clinical guidance focusing on patients with extreme concentrations (either low or high) of plasma low-density lipoprotein cholesterol, triglycerides, or high-density lipoprotein cholesterol. The task force also recognises the scarcity of qua…

medicine.medical_specialtyRare dyslipidaemiaConsensusSettore MED/09 - Medicina InternaGenotypediagnosisEndocrinology Diabetes and MetabolismMEDLINE030209 endocrinology & metabolism610 Medicine & health03 medical and health sciences0302 clinical medicineEndocrinologyRare DiseasesGenotype540 ChemistryInternal Medicinemedicinegeneome sequencingHumansgeneticsGenetic Predisposition to DiseaseRare dyslipidemias; genetics; diagnosis; treatment030212 general & internal medicineDisease management (health)Intensive care medicineHealth policyDyslipidemias10038 Institute of Clinical Chemistrytreatmentbusiness.industryTask forcegene therapiesDisease ManagementAtherosclerosisPhenotype1310 EndocrinologyEurope2712 Endocrinology Diabetes and MetabolismPhenotype2724 Internal MedicinePractice Guidelines as TopicRare dyslipidemiasEuropean atherosclerosis societylipids (amino acids peptides and proteins)businessQuality information
researchProduct

The use of clinical guidelines for referral of patients with lesions suspicious for oral cancer may ease early diagnosis and improve education of hea…

2010

UNLABELLED Early diagnosis and referral of oral cancer is essential. Successful implementation of clinical guidelines must include current practitioners and students. OBJECTIVE To evaluate the diagnostic accuracy of students at oral cancer screening and to assess the effectiveness of clinical referral guidelines. STUDY DESIGN Fifth year dental students were randomly allocated to either control (n=19) or experimental groups (n = 18). Both received the customary training in oral diagnosis. The experimental group underwent a 2 hour workshop where the guidelines for the referral of suspicious lesions were discussed. Three months later, a set of 51 clinical cases including benign, malignant, and…

medicine.medical_specialtyReferralConcordanceInternal medicineHumansMedicineOral DiagnosisEducation DentalReferral and ConsultationGeneral DentistryEarly Detection of CancerOral cancer screeningHealth professionalsbusiness.industryReproducibility of ResultsCancerGuidelinemedicine.disease:CIENCIAS MÉDICAS [UNESCO]SurgeryOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASPractice Guidelines as TopicOral CancersMouth NeoplasmsSurgerybusiness
researchProduct

EU-wide cross-sectional observational study of lipid-modifying therapy use in secondary and primary care: the DA VINCI study

2021

Abstract Aims To provide contemporary data on the implementation of European guideline recommendations for lipid-lowering therapies (LLTs) across different settings and populations and how this impacts low-density lipoprotein cholesterol (LDL-C) goal achievement. Methods and results An 18 country, cross-sectional, observational study of patients prescribed LLT for primary or secondary prevention in primary or secondary care across Europe. Between June 2017 and November 2018, data were collected at a single visit, including LLT in the preceding 12 months and most recent LDL-C. Primary outcome was the achievement of risk-based 2016 European Society of Cardiology (ESC)/European Atherosclerosis…

medicine.medical_specialtyRegistryStatinEpidemiologymedicine.drug_class030204 cardiovascular system & hematologyGuidelinesSecondary care03 medical and health sciences0302 clinical medicineEzetimibeRisk FactorsInternal medicinemedicineHumans030212 general & internal medicinePCSK9 InhibitorsDyslipidemiasSecondary preventionPrimary Health Carebusiness.industryAnticholesteremic AgentsStatinsCholesterol LDLGuidelineLipidsConfidence intervalCross-Sectional StudiesTreatment OutcomeCholesterolCardiovascular DiseasesObservational studyHydroxymethylglutaryl-CoA Reductase InhibitorsProprotein Convertase 9Cardiology and Cardiovascular MedicinebusinessBiomarkersmedicine.drugDA VINCI study
researchProduct

Psoriasis predisposition and occupational triggering factors in the appraisal of occupational medical expertises

2014

Summary Background Psoriasis is an immune-mediated disease with a genetic background. Local psoriatic changes can be triggered by exogenous mechanical or irritant factors. Causative occupational factors have to be distinguished from the spontaneous course of psoriasis in occupational medical evaluations. The objective of this work is to demonstrate the medico-legal grounds for a homogenous assessment. Patients and methods The presented recommendations were developed in a working group for Occupational and Environmental Dermatology (ABD) and the German contact dermatitis group (DKG) of the German Dermatologic Society (DDG) based on the German medico-legal framework. Results Causality between…

medicine.medical_specialtyRehabilitationbusiness.industrymedicine.medical_treatmentDermatologyGuidelineDiseasemedicine.diseaseCausalitylanguage.human_language3. Good healthSurgeryGermanExpert witnessPsoriasisFamily medicinemedicinelanguagePosition paperbusinessJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct

CPR - Guidelines 2000. Neue internationale Richtlinien für die kardiopulmonale Reanimation

2001

The "Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. An International Consensus an Science" are the first true international CPR guidelines in the history of resuscitation medicine. Experts from major international resuscitation organizations (International Liaison Committee on Resuscitation, ILCOR) achieved a consensus of recommendations which had to pass a rigorous review procedure applying the tools of evidence-based medicine: all proposed guidelines or guideline changes had to be based on critically appraised pieces of evidence which had to be integrated into a final class of recommendations. The most important changes compared to previous recommenda…

medicine.medical_specialtyResuscitationbusiness.industryhealth care facilities manpower and servicesmedicine.medical_treatmenteducationAdvanced cardiac life supportMEDLINEBasic life supportCardiovascular careGeneral MedicineReview procedureGuidelineCritical Care and Intensive Care Medicinemedicine.diseaseAnesthesiology and Pain MedicineEmergency MedicinemedicineCardiopulmonary resuscitationMedical emergencyIntensive care medicinebusinesshealth care economics and organizationsAINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie
researchProduct